SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 100 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,185,000 | +178.2% | 130,920 | +336.4% | 0.01% | +400.0% |
| Q2 2018 | $426,000 | +44.4% | 30,000 | +66.6% | 0.00% | +100.0% |
| Q4 2017 | $295,000 | +586.0% | 18,005 | +363.2% | 0.00% | – |
| Q2 2015 | $43,000 | -95.5% | 3,887 | -93.8% | 0.00% | -100.0% |
| Q4 2014 | $961,000 | +150.3% | 63,167 | +77.4% | 0.01% | +100.0% |
| Q3 2014 | $384,000 | -13.3% | 35,615 | -15.7% | 0.00% | -25.0% |
| Q3 2013 | $443,000 | +29.9% | 42,224 | -3.2% | 0.00% | 0.0% |
| Q2 2013 | $341,000 | – | 43,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |